Navigation Links
SenesTech, Inc. Commences Product Registration Process With Australian Government
Date:11/10/2008

FLAGSTAFF, Ariz., Nov. 10 /PRNewswire/ -- SenesTech, Inc. has launched the regulatory process to register both the active ingredient and the first ContraPest(R) product with the government of Australia. In parallel with laboratory research and testing in the rice field rat species, registration of ContraPest(R) bait will open the door for marketing this unique rodent population management product to the agricultural ministries of Southeast Asia. ContraPest(R) will target the rice field rat, a major rodent pest species for rice agriculture in this region, known to eat or damage a significant portion of rice crops each year.

ContraPest(R) works through disruption of the reproductive potential of female rodents by selectively eliminating the female's supply of egg cells. The direct effect will be to drastically reduce the number of rats in the field. This translates to increased rice yield, and since nearly half of the world's population depends on rice for sustenance, a 10 percent increase in rice yield will feed approximately 380 million people per year. A further benefit to this humane approach to pest population control is the reduced potential for disease, since rodents and their carcasses are vectors for many human illnesses, some life-threatening.

The regulatory process for ContraPest(R) has been initiated with the Australian Pesticides and Veterinary Medicines Authority (APVMA), the Australian agency responsible for oversight of all agricultural chemical and related products that are manufactured or used in Australia. This registration process will be guided by direct consultation with regulatory expertise within the Australian government.

"The APVMA largely sets the standards for agricultural product use in Australasia, so gaining registration by the APVMA will mean nearly instantaneous acceptance of the product by governments with rice-based agriculture across the region," says Timothy L. Vail, Ph.D., Vice President of Manufacturin
'/>"/>

SOURCE SenesTech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
2. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
3. Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
4. Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share
5. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
6. Phase 1b/2a Program Commences for RVX-208
7. GSI Group Accepts Shares in Tender Offer for Excel Technology and Commences Subsequent Offering Period
8. Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period
9. Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMeds Selective Kinase Inhibitor
10. GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
11. Arbios Commences Process to Seek European Marketing Approval for SEPET(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...New York investment bank KTA Capital,s client Neur...6.7 mil convertible note private placement with a ... was arranged by KTA Capital as Neuren,s exclusive... New York (PRWEB) November 23, 2009 -- The i...LC ("KTA Capital") has announced that it...
(Date:11/24/2009)... 24 Sigma-Aldrich Corpor...ASDAQ OMX conference on Tuesday, December 1st at 1...arties may listen via live audio broadcast over th... m a a ldrich.com/ . Users can click the "Web...gma-Aldrich: Sigma-Aldrich is a leading Life Sci...
(Date:11/24/2009)...if., Nov. 24 NeurogesX, ... focused on developing and commercializing novel p...hony DiTonno, President and Chief Executive Office...r Jaffray Health Care Conference, to be held Decem...York, New York. ,, Mr. DiTonno and Stephen Ghi...
(Date:11/24/2009)...cacy endpoint has been met for patients with advan..., QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - ...the "Company"), a global biopharmaceutical company...announced positive efficacy data from a Phase 2 st... AEZS-108 (formerly AN-152), in patients with adva...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...ektar Therapeutics,(Nasdaq: NKTR ) announced tod...,Directors effective January 23, 2009. Mr. Lerner...een a member of the Nektar Board of Directors,sinc... The Board of Directors and the Company wish t...s made by providing the benefit of his,extensive i...
...9 ThermoGenesis,Corp. (Nasdaq: KOOL ), a leadin... store adult stem cells, announced today it will r...ter ended December 31, 2008, on Wednesday, Februar...cast , Management will host a conference call ...00 PM Eastern) to review the fiscal second quarter...
...f Kingdee enterprise accounting system across its ...., Jan. 29 AMDL, Inc. (NYSE Alternext US: ADL), a... operations in China and the US, announced today i...enterprise accounting system across its US and Chi...sed Kingdee International Software, the new accoun...
Other Biology Technology:ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009 2AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 2AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 3AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 4
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
(Date:11/25/2009)... Athens, Ga. Bacteria don,t have easy lives. In a...he bugs, they have natural enemies called bacterio...th every two days. , Still, bacteria and anothe...scovered in extreme environments such as deep-sea ...rt because they have a built-in defense system tha...
(Date:11/25/2009)... Over the course of a lifetime, the heart pumps so...n the order to do this, the muscle fibers of the h...oup headed by Dr. Wolfgang Rottbauer, vice chair o...versity Hospital (Chairman: Prof. Dr. H. A. Katus)... the stability of the smallest muscular unit, the ...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2CCMC Celebrates Case Management Week 28Oct 11 17 29 With Second Annual Patricia McCollom Scholarship 58859 1CCMC Celebrates Case Management Week 28Oct 11 17 29 With Second Annual Patricia McCollom Scholarship 58859 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 1Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 3Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 4Lincare Holdings Inc Extends Terms of Employment Agreements with Executive Officers 5219 1Lincare Holdings Inc Extends Terms of Employment Agreements with Executive Officers 5219 2
...quences from tiny green algae have provided new in...kton evolve—and further highlights their critical ...ese findings, by a group led by the DOE Joint Geno... Oceanography, University of California, San Diego...e published this week in the Proceedings of the Na...
... potentially assist cancer diagnosis, a new optica...ional images of blood vessels by taking advantage ...s of hemoglobin, the red-blood-cell molecule that ...earch will be presented in Baltimore at CLEO/QELS,...loped at Duke University, should provide 3-D image...
... Institute for Biological Studies have identified ...in healthy muscle and restores normal muscle funct...es. The study, published online in Nature Medicine...ys in a cascade of events triggered by exercise-in...cular pathway, a molecular switch turns on a set o...
Other Biology News:Puzzling plankton yield secrets to role in evolution/global photosynthesis 2Puzzling plankton yield secrets to role in evolution/global photosynthesis 3Catching cancer's spread by watching hemoglobin 2Catching cancer's spread by watching hemoglobin 3Salk scientists hammer out a pathway that promotes muscle cell survival in mice 2
Propidium Iodide Buffer from BioLegend
Mouse Anti-Escherichia coli Lac1 Monoclonal Antibody, Unconjugated, Clone 0.T.81 from Abcam
Goat Anti-Human HADHB Polyclonal Antibody, Unconjugated from IMGENEX
EDG-6 Lysate from Exalpha Biologicals, Inc.
Biology Products: